Some traders at the Central Business District (CBD) of Accra on Monday expressed optimism about the Nibima herbal preparation under clinical trial for the treatment of COVID-19.
The herbal medicine Cryptolepis Sanguinolenta, locally known as Nibima was recently approved by Ghana Food and Drugs Authority (FDA) for clinical trials for the treatment of COVID-19.
A visit by the Ghana News Agency (GNA) to some Herbal wholesale and retail shops at Okaishie Drug Lane and the CBD of Accra, the traders expressed confidence that the product would be the preferred option to many.
Mr. Meshack Abeka, Sales Manager, Angel Herbal, said demand for the product would be a “hotcake”, adding that he anticipates the possibility of a rush when approved by the FDA for treatment of COVID-19.
“Some Ghanaians often patronizes products based on the big adverts but not necessary its efficacy,” he said.
He also commended the FDA who occasionally visit herbal shops pick some products and re-examine their efficacy to ensure that most of these shop maintain the approved standards.
He claimed that some producers present the right samples to the Authorities for approval but afterward because of monetary considerations reduce the standards for mass production, which they push onto the market.